Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Catalyst Biosciences Inc. (NASDAQ: CBIO).

Full DD Report for CBIO

You must become a subscriber to view this report.


Recent News from (NASDAQ: CBIO)

Biotechs Emerge Unscathed And Ready To Go!
Biotech Pulse Biotechs have a pulse now, and it's beginning to beat a little harder! As President Trump on Friday, May 11, delivered a blueprint, American Patients First , to lower drug prices the early indications appear to be that the biotech and pharmaceutical industries have jumped th...
Source: SeekingAlpha
Date: May, 15 2018 08:28
Catalyst Biosciences Announces Oral Presentation at the World Federation of Hemophilia 2018 World Congress
SOUTH SAN FRANCISCO, Calif., May 10, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ:CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology indications, today announced an oral presentation of clinical safety data from the P...
Source: GlobeNewswire
Date: May, 10 2018 09:01
Catalyst Biosciences to Host Key Opinion Leader Meeting on Novel Treatments for Hemophilia B and Hemophilia with Inhibitors
SOUTH SAN FRANCISCO, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ:CBIO), today announced that it will host a Key Opinion Leader (KOL) breakfast on the topic of novel treatments for hemophilia B and hemophilia with inhibitors at 8:00 a.m. EDT on May 14, 2018 in...
Source: GlobeNewswire
Date: May, 09 2018 18:07
Small Caps: The Bright Spot In A Challenging Stock Market
Market Pulse The stock market is unpredictable and volatile and investors are being administered a high dosage of these nerve-wracking reminders during 2018. The high volatility this year appears to feel like a punishment meted out for the low-volatility indulgences of a mellow 2017 when sto...
Source: SeekingAlpha
Date: May, 07 2018 15:21
Catalyst beats by $0.13
Catalyst (NASDAQ: CBIO ): Q1 EPS of -$0.56 beats by $0.13 . Revenue of $6K Press Release More news on: Catalyst Inc., Earnings news and commentary, Healthcare stocks news,
Source: SeekingAlpha
Date: May, 03 2018 15:14
Catalyst Biosciences Reports First Quarter Operating & Financial Results and Provides Corporate Update
Announced Korean Ministry of Food and Drug Safety approval to add sixth cohort to the Phase 1/2 trial of CB 2679d/ISU304 in individuals with hemophilia B Raised approximately $106.8 million in an underwritten public offering Received $1.5 million in two milestone payments for...
Source: GlobeNewswire
Date: May, 03 2018 08:00
Key events next week - healthcare
Noteworthy events during the week of April 29 - May 5 for healthcare investors. More news on: EyePoint Pharmaceuticals, Inc., Catalyst Inc., Johnson & Johnson, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: April, 27 2018 15:34
Catalyst Biosciences Announces Presentation at the 2018 Association for Research in Vision and Ophthalmology Annual Meeting
SOUTH SAN FRANCISCO, Calif., April 23, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ:CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology indications, today announced a poster presentation with collaborator Mosaic Biosci...
Source: GlobeNewswire
Date: April, 23 2018 08:00
3 Things In Biotech, April 14: Organovo, Catalyst, And Aeglea Open Up
Note: Subscribers to Avisol Capital Partners Total Pharma Tracker got an early look at this publication. Try for free today and see what we're talking about! Welcome to another edition of "3 Things In Biotech," a daily digest dedicated to helping you keep pace with the fast-moving worl...
Source: SeekingAlpha
Date: April, 15 2018 08:00
Biotechs, Whipsawed By Volatility, Still Remain Well-Positioned
Biotech Pulse When the market experiences rain, biotechs experience a thunderstorm. That's how volatility relates to biotechnology - one of the most promising and nerve-wracking industries in the stock market. As the market succumbed last week to the drumbeat of a tariff war, volatility sp...
Source: SeekingAlpha
Date: April, 13 2018 09:17

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-08-1710.4210.3210.5110.17163,459
2018-08-1610.1410.360110.479.96140,953
2018-08-1510.1510.1410.49979.93238,815
2018-08-1410.1510.2310.419.999153,001
2018-08-1310.1210.1510.349.97140,391

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-1711,87048,82424.3118Cover
2018-08-1622,18349,89144.4629Short
2018-08-1559,85190,63766.0337Short
2018-08-1415,28358,32526.2032Cover
2018-08-1317,66733,12153.3408Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on CBIO.


About Catalyst Biosciences Inc. (NASDAQ: CBIO)

Logo for Catalyst Biosciences Inc. (NASDAQ: CBIO)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $317,356,144 - 05/14/2018
  • Issue and Outstanding: 11,935,169 - 04/30/2018

 


Recent Filings from (NASDAQ: CBIO)

Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: May, 11 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 03 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 03 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: April, 16 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 13 2018
Amendment to a previously filed Form 4
Filing Type: 4/AFiling Source: edgar
Filing Date: March, 21 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: March, 19 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 05 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 26 2018

 

 


Daily Technical Chart for (NASDAQ: CBIO)

Daily Technical Chart for (NASDAQ: CBIO)


Stay tuned for daily updates and more on (NASDAQ: CBIO)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: CBIO)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CBIO is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of CBIO and does not buy, sell, or trade any shares of CBIO. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/